The struggling genetic-testing 23andMe is looking for a buyer for the virtual-care business it acquired in 2021, Business ...

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

23andMe's big push into drug development ... The company that made its name by providing saliva-based genetic testing for health and ancestry to millions of people around the world made the ...

The 23andMe Health + Ancestry Personal Genetic DNA Test offers just that — an opportunity to kickstart these goals by providing valuable insights into your genetic makeup and ancestral origins.

23andMe Holding Co. is currently trading with a market capitalization of $85.55 million, reflecting its position as a smaller player in the genetic testing market. The stock's trading volume sits ...

They did 23andMe a few years after my siblings and I did. One cousin showed up as a half-sibling, one showed up as a ...

23andMe faced major hurdles in 2024 ... She said the biotech company, which offers direct-to-consumer genetic testing, made strides with its new preventive care membership service, signed a ...

23andMe's stock plummeted after a 2023 data breach exposed millions of customer accounts. The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its ...